Texas Equine Veterinary Association

2022 The Remuda Summer Symposium Edition

Texas Equine Veterinary Association Publications

Issue link: http://read.uberflip.com/i/1470568

Contents of this Issue

Navigation

Page 35 of 59

36 2 Giralda Farms • Madison, NJ 07940 • merck-animal-health-usa.com • 800-521-5767 Copyright © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-PRA-210600001 IMPORTANT SAFETY INFORMATION: Use of PROTAZIL ® (1.56% diclazuril) Antiprotozoal Pellets is contraindicated in horses with known hypersensitivity to diclazuril. Safe use in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated. The safety of PROTAZIL ® (1.56% diclazuril) Antiprotozoal Pellets with concomitant therapies in horses has not been evaluated. For use in horses only. Do not use in horses intended for human consumption. Not for human use. Keep out of reach of children. Ask your Merck Animal Health Equine representative about PROTAZIL ® or call 800-521-5767. 1 Hunyadi L, Papich MG, Pusterla N. Pharmacokinetics of a low-dose and DA-labeled dose of diclazuril administered orally as a pelleted top dressing in adult horses. J of Vet Pharmacology and Therapeutics (accepted) 2014, doi: 10.111/jvp.12176. The correlation between pharmacokinetic data and clinical effectiveness is unknown Effectively treating Equine Protozoal Myeloencephalitis (EPM) doesn't have to be difficult. Reach for PROTAZIL ® (1.56% diclazuril) Antiprotozoal Pellets • Goes to work fast (within 12 hours) — no loading dose required 1 • The only FDA-approved alfalfa-based top dress treatment for EPM, proven safe and effective • No mess, no fuss - easy to administer and highly palatable Get the scoop on EPM RECOVERY

Articles in this issue

Links on this page

view archives of Texas Equine Veterinary Association - 2022 The Remuda Summer Symposium Edition